Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results

被引：4
|
作者：
Gentzler, R. D. [1 ]
Mohindra, N. A. [2 ]
Hanna, N. [3 ]
Chae, Y. K. [4 ]
Jalal, S. I. [3 ]
Hall, R. [1 ]
Villaflor, V. M. [2 ]
Reckamp, K. L. [5 ]
Koczywas, M. [5 ]
Sullivan, D. [6 ]
Wood, L. [6 ]
Patel, J. D. [7 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
[4] Northwestern Univ, Dev Therapeut Program, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA
[5] City Hope Comprehens Canc Ctr, Duarte, CA USA
[6] Hoosier Canc Res Network, Indianapolis, IN USA
[7] Univ Chicago, Chicago, IL 60637 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 98卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2017.01.161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [1] nab-Paclitaxel plus Carboplatin in Advanced Non-Small Cell Lung Cancer NSCLC: Dose Modification Analysis
    Postmus, Pieter E.
    O'Brien, Mary E. R.
    Socinski, Mark A.
    Li, Li
    Ong, Teng Jin
    Gridelli, Cesare
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S658 - S658
  • [2] Real-world outcomes of pembrolizumab plus carboplatin plus paclitaxel or nab-paclitaxel in non-small cell lung cancer (NSCLC).
    Tabah, Ashley
    Huggar, David
    Kish, Jonathan
    Bapat, Bela
    Liassou, Djibril
    Gajra, Ajeet
    Miller, Talia
    Copher, Ronda
    Patel, Manali, I
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] NAB-PACLITAXEL IN COMBINATION WITH CARBOPLATIN AS FIRST-LINE THERAPY IN DIABETIC PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Hirsh, Vera
    Owen, Scott
    Ko, Amy
    Renschler, Markus F.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S584 - S584
  • [4] A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations
    Baik, Christina
    Goulart, Bernardo
    Nguyen, Katherine
    Lee, Sylvia
    Eaton, Keith
    Chow, Laura
    Rodriguez, Cristina
    Santana-Davila, Rafael
    Wood, Rebecca
    Martins, Renato
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1227
  • [5] Interim Results From the Phase I Study of Nivolumab plus nab-Paclitaxel plus Carboplatin in Non-Small Cell Lung Cancer (NSCLC)
    Goldman, Jonathan W.
    George, Ben
    Gutierrez, Martin
    Ko, Amy
    O'Dwyer, Peter
    Otterson, Gregory
    Soliman, Hatem
    Trunova, Nataliya
    Waterhouse, David
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1309 - S1309
  • [6] Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis G.
    Luft, Alexander
    Tafreshi, Ali
    Gumus, Mahmut
    Mazieres, Julien
    Hermes, Barbara
    Senler, Filiz Cay
    Fulop, Andrea
    Rodriguez-Cid, Jeronimo
    Sugawara, Shunichi
    Cheng, Ying
    Novello, Silvia
    Halmos, Balazs
    Yue Shentu
    Kowalski, Dariusz
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Efficacy and safety of weekly nab-paclitaxel plus carboplatin advanced non-small cell lung cancer
    Satouchi, Miyako
    Okamoto, Isamu
    Sakai, Hiroshi
    Yamamoto, Nobuyuki
    Ichinose, Yukito
    Ohmatsu, Hironobu
    Nogami, Naoyuki
    Takeda, Koji
    Mitsudomi, Tetsuya
    Kasahara, Kazuo
    Negoro, Shunichi
    LUNG CANCER, 2013, 81 (01) : 97 - 101
  • [8] nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis
    Langer, Corey J.
    Gajra, Ajeet
    Gridelli, Cesare
    Konduri, Kartik
    Morgensztern, Daniel
    Spigel, David
    Talbot, Denis
    Thomas, Michael
    Weiss, Jared
    Pilot, Richard
    Bhore, Rafia
    Wolfsteiner, Marianne
    Ong, Teng Jin
    Socinski, Mark
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [9] First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study
    Dechow, Tobias
    Riera-Knorrenschild, Jorge
    Hackanson, Bjoern
    Janssen, Jan
    Schulz, Holger
    Chiabudini, Marco
    Fischer von Weikersthal, Ludwig
    Budweiser, Stephan
    Nacke, Axel
    Taeuscher, Dagmar
    Welslau, Manfred
    Potthoff, Karin
    CANCER MEDICINE, 2021, 10 (22): : 8127 - 8137
  • [10] nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
    Gridelli, Cesare
    Chen, Tianlei
    Ko, Amy
    O'Brien, Mary E.
    Ong, Teng Jin
    Socinski, Mark A.
    Postmus, Pieter E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1445 - 1451
12345